Interesting Finding: Reduced Alcohol Cravings Interestingly, recent research has found that GLP-1 medications may actually reduce alcohol cravings and consumption in some individuals: Studies have shown that both semaglutide (GLP-1 agonist) and tirzepatide (GLP-1/GIP combination) appear to effectively reduce alcohol consumption in individuals with obesity
According to research published in Nature Medicine in 2024, there may be neuroprotective effects, with researchers indicating that 30-40% of the risk of dementia could be reduced in long-term users of GLP-1
Biol Trace Elem Res 2017;176:5663
R., & Clancy, S
[DOI] [PMC free article] [PubMed] [Google Scholar] 86.Rudrapal M., Khairnar S.J., Khan J., Dukhyil A.B., Ansari M.A., Alomary M.N., Alshabrmi F.M., Palai S., Deb P.K., Devi R
James LP, Mayeux PR